PHOENIX—The Alport Syndrome Foundation, Inc. (ASF) and the Kidney Foundation of Canada (KFOC) are pleased to announce the availability of funding for basic science and clinical research on the natural history, biochemical basis, and treatment of Alport Syndrome. There are no geographical limitations of this funding.
The objective of this research funding program is to advance the knowledge of, develop effective treatment protocols for, and discover a cure for Alport Syndrome Foundation.
ASF and KFOC are seeking proposals for both basic science and clinical research that will enhance understanding of the causes of this genetic disorder to advance the mission of our organizations.
Types of Proposals Sought
ASF and KFOC are interested in providing funding to young investigators as well as attracting experienced investigators to the field of Alport Syndrome basic science or clinical research. These funds may be used as “seed funding” for the testing of initial hypotheses and the collection of preliminary data leading to successful long-term funding by the National Institutes of Health (NIH), the Canadian Institutes of Health Research (CIHR), and other major funding institutions around the world.
ASF and KFOC anticipate funding two research projects totaling $100,000 each, over a one-to two-year timeframe. Funds will be available by July 1. Successful applicants will be notified in May in accordance with the ASF Macquarie KFOC Research Funding Program.
ASF and KFOC have a competitive funding process. Applications should be of 10 to 15 pages in length and must follow the instructions of the ASF Macquarie KFOC Research Funding Program. In general terms, detailed information about the specific aims, significance, research design and methods, personnel, facilities, and budget will be required, along with evidence of application to the relevant Institutional Review Board for any work involving human subjects or to the Animal Use and Protection Committee for any work involving animal subjects.
Research proposals will be evaluated by a joint ASF and KFOC peer review committee (as well as expert outside reviewers, as required) in accordance with the ASF Macquarie KFOC Research Funding Program. Based on the input from the review committee and outside reviewers, two research applications will be funded.
The deadline for submission of completed research funding applications is March 1 by 5:00 p.m. Arizona Time/MST (no late submittals will be accepted).
For Additional Information, go to www.alportsyndrome.org or Contact:
President, Alport Syndrome Foundation, Inc.
National Director of Research, The Kidney Foundation of Canada Foundation, Inc.
Telephone: 1-514-369-4806 ext. 225